Demonstrating significant expertise in the biotech and pharma sectors, the Ropes & Gray LLP practice is highly regarded for representing clients in strategic combination agreements and complex take-private sales. The firm represents a diverse array of domestic and global corporations, including Pfizer, Blackstone, and Medtronic, with Boston-based practice head Christopher Comeau noted for his ability to counsel these clients on strategic acquisitions and minority investments. Also in Boston, Mike Beauvais is an expert on private securities offerings and financings and Zachary Blume focuses on corporate governance issues, while New York-based lawyer Jackie Cohen has experience handling joint ventures and spin-offs. Further key contacts in New York include Ariel Deckelbaum, who concentrates primarily on restructuring transactions, and Carl Marcellino, who routinely acts for private equity funds on investments and leveraged buyouts.
Legal 500 Editorial commentary
- Profile
Key clients
- Adaptimmune Therapeutics
- AlerisLife Inc.
- America’s Test Kitchen Limited Partnership
- Blackstone Inc.
- Cinven/Drake Software
- CIRCOR International, Inc.
- Crosspoint Capital Partners LP
- Deutsche Bank Securities
- Drake Software
- EnergySolutions
Work highlights
- Represented CIRCOR International in a take-private sale to KKR in a cash transaction valued at approximately $1.8bn including debt.
- Represented Provention Bio in its $2.9bn sale to Sanofi.
- Represented CIRCOR International in its $1.6bn contested take-private acquisition by KKR.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Christopher Comeau
Other key lawyers
Mike Beauvais; Zach Blume; Jackie Cohen; Ariel Deckelbaum; Julie Jones; Carl Marcellino